News
This came after Sun Pharma presented the BE study report along with revised clinical trial (CT) protocol no. ICR/23/013 ver.
2d
MedPage Today on MSNWhich AI Would Make the Best Doctor?In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike" on YouTube, takes a look at the best artificial intelligence ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
6d
Parade on MSNExperts Recommend This Food Swap to Lower Insulin ResistanceDr. Graham Simpson, MD, who is board-certified in internal medicine, anti-aging medicine and emergency medicine, and is the ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
The International Diabetes Federation (IDF) has recognised Type 5 diabetes as a form driven by malnutrition rather than ...
Conduct CT in India: CDSCO Panel tells Novo Nordisk India For new formulation of Semaglutide tablets
The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...
2don MSN
The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of ...
Intermittent fasting shows promise in enhancing cognitive function and supporting brain health, with implications for ...
In 2022, a study published by Dr. Hawkins and her colleagues at Christian Medical College in Vellore, India, demonstrated ...
Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.
Research shows that the biological parents' genes affect the child's insulin function and capacity to regulate blood sugar levels and blood lipids in different ways. Such knowledge may be used to to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results